Antibiotic consumption and resistance selection in Streptococcus pneumoniae

被引:84
|
作者
Baquero, F
Baquero-Artigao, G
Cantón, R
García-Rey, C
机构
[1] Hosp Ramon y Cajal, Dept Microbiol, E-28034 Madrid, Spain
[2] Microbial Sci Fdn, Madrid 28024, Spain
[3] GlaxoSmithKline, Dept Med, Madrid, Spain
关键词
D O I
10.1093/jac/dkf504
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Selection of antibiotic-resistant Streptococcus pneumoniae is an inescapable consequence of antibiotic use. The correlation between antibiotic consumption and selection of resistant organisms can be shown at every ecological level: patient, community, region or country. In the case of multiple resistance, the intensity of antibiotic selection is increased. However, different antibiotics may exert different selective powers. Because of this, co-selection of macrolide and beta-lactam resistance is an asymmetrical phenomenon: macrolides select more efficiently strains resistant to both macrolides and beta-lactams than aminopenicillins. The difference in rates of antibiotic resistance is also influenced by the local spread of susceptible or resistant clones; it is suggested that under mild antibiotic selection, the susceptible organisms that are more fit for host-to-host transmission could be favoured. Subsequent acquisition of resistance in these clones may rapidly increase the prevalence of resistance, and that may lead to an increase in the use of antibiotics. The reasons for antibiotic resistance are mainly the reasons explaining antibiotic consumption. A number of possible sociobiological determinants of antibiotic consumption can be identified: genetic factors in the human populations (for instance, involving different symptomatic types of infection), cultural factors and attitudes of patients towards antibiotics, sociological factors or public health factors, including incidence of other infectious diseases in the human population. Only 'excess' in the use of antibiotics should be controlled; for such a purpose, the concept, 'appropriate demand for antibiotics' (ADA) is proposed.
引用
收藏
页码:27 / 37
页数:11
相关论文
共 50 条
  • [31] ANTIBIOTIC-RESISTANCE IN STREPTOCOCCUS PNEUMONIAE AND HEMOPHILUS-INFLUENZAE
    HOWARD, AJ
    WILLIAMS, JD
    BRITISH MEDICAL JOURNAL, 1978, 2 (6142): : 954 - 954
  • [32] Virulence factors, antibiotic resistance mechanisms and the prevalence of resistance worldwide in Streptococcus pneumoniae
    Dobay, O
    Rozgonyi, F
    Amyes, SGB
    REVIEWS IN MEDICAL MICROBIOLOGY, 2004, 15 (01) : 27 - 39
  • [33] PHLS surveillance of antibiotic resistance, England and Wales: Emerging resistance in Streptococcus pneumoniae
    Speller, DCE
    Johnson, AP
    Cookson, BD
    Waight, P
    George, RC
    EMERGING INFECTIOUS DISEASES, 1996, 2 (01) : 57 - 58
  • [34] Antibiotic resistant Streptococcus pneumoniae
    Minton, EJ
    Macfarlane, JT
    THORAX, 1996, 51 : S45 - S50
  • [35] Antibiotic therapy for community acquired Streptococcus pneumoniae pneumonia:: clinical relevance of antibiotic resistance
    Bedos, J. -P.
    Bruneel, F.
    MEDECINE ET MALADIES INFECTIEUSES, 2006, 36 (11-12): : 667 - 679
  • [36] The murMN operon:: A functional link between antibiotic resistance and antibiotic tolerance in Streptococcus pneumoniae
    Filipe, SR
    Severina, E
    Tomasz, A
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (03) : 1550 - 1555
  • [37] In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae
    Nagai, K
    Davies, TA
    Pankuch, GA
    Dewasse, BE
    Jacobs, MR
    Appelbaum, PC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) : 2740 - 2746
  • [38] In vitro selection of resistance to four β-lactams and azithromycin in Streptococcus pneumoniae
    Pankuch, GA
    Jueneman, SA
    Davies, TA
    Jacobs, MR
    Appelbaum, PC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 2914 - 2918
  • [39] Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance
    Fiore, AE
    Moroney, JF
    Farley, MM
    Harrison, LH
    Patterson, JE
    Jorgensen, JH
    Cetron, M
    Kolczak, MS
    Breiman, RF
    Schuchat, A
    CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) : 71 - 77